Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CALCRL | Q16602 | 3/20 | 0.42 |
| ▸ | FNTA | P49354 | 3/20 | 0.42 |
| ▸ | FNTB | P49356 | 3/20 | 0.42 |
| ▸ | CMA1 | P23946 | 2/20 | 0.42 |
| ▸ | XIAP | P98170 | 1/20 | 0.42 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.41 |
| ▸ | TSHR | P16473 | 1/20 | 0.40 |
| ▸ | GRB2 | P62993 | 1/20 | 0.40 |
| ▸ | ACE | P12821 | 2/20 | 0.39 |
| ▸ | REN | P00797 | 2/20 | 0.39 |
| ▸ | CTSD | P07339 | 1/20 | 0.38 |
| ▸ | BACE1 | P56817 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25286046 | 1.00 | CALCRL (0.42) | CALCRLFNTAFNTBCMA1XIAP | |
| SCHEMBL29482771 | 0.88 | SLC6A2 (0.57) | CALCRLSLC6A2REN | |
| SCHEMBL29511796 | 0.83 | ACE (0.47) | CALCRLACERENBACE1 | |
| SCHEMBL30304780 | 0.83 | NTSR1 (0.46) | FNTAFNTB | |
| SCHEMBL30830432 | 0.82 | FNTA (0.44) | CALCRLFNTAFNTBCMA1XIAP | |
| SCHEMBL30051244 | 0.82 | XIAP (0.56) | FNTAFNTBXIAPTSHR | |
| SCHEMBL30658554 | 0.81 | ACE (0.49) | CALCRLACEREN | |
| SCHEMBL30987363 | 0.81 | NMUR2 (0.41) | GRB2CTSDBACE1 | |
| SCHEMBL8838927 | 0.81 | CALCRL (0.46) | CALCRLCTSDBACE1 | |
| SCHEMBL8838938 | 0.81 | CALCRL (0.46) | CALCRLCTSDBACE1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4203988-A2 | PEPTIDE INHIBITORS OF NF KAPPA B AND USE THEREOF IN TREATMENT OF COVID-19 AND INFLAMMATORY DISEASES | Bhatnagar, Rajendra, Sahai (US) | 2023-07-05 | — | — | EP | disclosed |